A Review on The Protective Effects of Metformin in Sepsis-Induced Organ Failure

Overview

Journal Cell J

Specialty Cell Biology

Date 2019 Aug 4

PMID 31376317

Citations 26

Authors

Fatima Ismail Hassan

Tina Didari

Fazlullah Khan

Kamal Niaz

Mojtaba Mojtahedzadeh

Mohammad Abdollahi

Affiliations

Soon will be listed here.

Abstract

Despite advances in sepsis management, it remains a major intensive-care-unit (ICU) concern. From new prospective, positive effects of metformin, such as anti-oxidant and anti-inflammatory properties are considered potentially beneficial properties for management of septic patients. This article reviewed the potential ameliorative effects of metformin in sepsis-induced organ failure. Information were retrieved from PubMed, Scopus, Embase, and Google Scholar. Multi-organ damage, oxidative stress, inflammatory cytokine stimulation, and altered circulation are hallmarks of sepsis. Metformin exerts its effect via adenosine monophosphate-activated protein kinase (AMPK) activation. It improves sepsis-induced organ failure by inhibiting the production of reactive oxygen species (ROS) and pro-inflammatory cytokines, preventing the activation of transcription factors related to inflammation, decreasing neutrophil accumulation/infiltration, and also maintaining mitochondrial membrane potential. Studies reported the safety of metformin therapeutic doses, with no evidence of lactic acidosis, in septic patients.

Citing Articles

Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function.

Ommati M, Mohammadi H, Mousavi K, Azarpira N, Farshad O, Dehghani R Liver Res. 2025; 5(3):171-180.

PMID: 39957842 PMC: 11791814. DOI: 10.1016/j.livres.2020.12.001.

The potential protective role of carotenoids from saffron: A focus on endoplasmic reticulum stress-related organ damage.

Mirzavi F, Rajabian A, Hosseini H Food Sci Nutr. 2024; 12(9):6108-6122.

PMID: 39554322 PMC: 11561782. DOI: 10.1002/fsn3.4289.

Targeting AMP-activated protein kinase in sepsis.

Yumoto T, Coopersmith C Front Endocrinol (Lausanne). 2024; 15:1452993.

PMID: 39469575 PMC: 11513325. DOI: 10.3389/fendo.2024.1452993.

From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction.

Srdic T, durasevic S, Lakic I, Ruzicic A, Vujovic P, Jevdovic T Int J Mol Sci. 2024; 25(14).

PMID: 39063011 PMC: 11277140. DOI: 10.3390/ijms25147770.

Metformin Mitigates Sepsis-Induced Acute Lung Injury and Inflammation in Young Mice by Suppressing the S100A8/A9-NLRP3-IL-1β Signaling Pathway.

Fan S, Zhao Z, Liu X, Peng Y, Zhu H, Yan S J Inflamm Res. 2024; 17:3785-3799.

PMID: 38895139 PMC: 11182881. DOI: 10.2147/JIR.S460413.

References

Opal S, DePalo V . Anti-inflammatory cytokines. Chest. 2000; 117(4):1162-72. DOI: 10.1378/chest.117.4.1162. View

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

Bilevicius E, Dragosavac D, Dragosavac S, Araujo S, Falcao A, Terzi R . Multiple organ failure in septic patients. Braz J Infect Dis. 2001; 5(3):103-10. DOI: 10.1590/s1413-86702001000300001. View

Mannick J, Rodrick M, Lederer J . The immunologic response to injury. J Am Coll Surg. 2001; 193(3):237-44. DOI: 10.1016/s1072-7515(01)01011-0. View

Wang J, Doyle M, Manning B, Blankson S, Wu Q, Power C . Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J Immunol. 2002; 170(1):14-8. DOI: 10.4049/jimmunol.170.1.14. View

De Vriese A . Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol. 2003; 14(3):792-805. DOI: 10.1097/01.asn.0000055652.37763.f7. View

Wang D, Kusuhara H, Kato Y, Jonker J, Schinkel A, Sugiyama Y . Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol. 2003; 63(4):844-8. DOI: 10.1124/mol.63.4.844. View

Holmes C, Russell J, Walley K . Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003; 124(3):1103-15. DOI: 10.1378/chest.124.3.1103. View

Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View

10.

Dellinger R, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32(3):858-73. DOI: 10.1097/01.ccm.0000117317.18092.e4. View

11.

Nguyen H, Rivers E, Knoblich B, Jacobsen G, Muzzin A, Ressler J . Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004; 32(8):1637-42. DOI: 10.1097/01.ccm.0000132904.35713.a7. View

12.

Power C, Wang J, Manning B, Kell M, Aherne N, Aherne N . Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol. 2004; 173(8):5229-37. DOI: 10.4049/jimmunol.173.8.5229. View

13.

Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N . Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes. 2005; 54(7):2179-87. DOI: 10.2337/diabetes.54.7.2179. View

14.

Bergheim I, Luyendyk J, Steele C, Russell G, Guo L, Roth R . Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther. 2005; 316(3):1053-61. DOI: 10.1124/jpet.105.092122. View

15.

Gras V, Bouffandeau B, Montravers P, Lalau J . Effect of metformin on survival rate in experimental sepsis. Diabetes Metab. 2006; 32(2):147-50. DOI: 10.1016/s1262-3636(07)70261-6. View

16.

Hinke S, Martens G, Cai Y, Finsi J, Heimberg H, Pipeleers D . Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer. Br J Pharmacol. 2007; 150(8):1031-43. PMC: 2013909. DOI: 10.1038/sj.bjp.0707189. View

17.

Chiba H, Osanai M, Murata M, Kojima T, Sawada N . Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2007; 1778(3):588-600. DOI: 10.1016/j.bbamem.2007.08.017. View

18.

El-Mir M, Detaille D, R-Villanueva G, Delgado-Esteban M, Guigas B, Attia S . Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci. 2007; 34(1):77-87. DOI: 10.1007/s12031-007-9002-1. View

19.

van der Poll T, Opal S . Host-pathogen interactions in sepsis. Lancet Infect Dis. 2007; 8(1):32-43. DOI: 10.1016/S1473-3099(07)70265-7. View

20.

Bhamra G, Hausenloy D, Davidson S, Carr R, Paiva M, Wynne A . Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol. 2007; 103(3):274-84. DOI: 10.1007/s00395-007-0691-y. View